Age

18–50

Sex

ALL

Healthy volunteers

Accepted

Participant is aged 18 to 50 years, inclusive, at the time of signing informed consent.
Overall healthy as determined by medical evaluation including physical examination, vital signs, laboratory tests, and ECG.

Participant has a history of clinically significant hypersensitivity to any excipients of the study drug
Participant is pregnant, breastfeeding, or \<6 weeks postpartum.
Participant has received investigational drug or device in another clinical study within 30 days or 5 half-lives, whichever is longer, before dosing.

A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers